Co-Founder of The Milner Institute, Director HealX Ltd, and Deputy Chairman Abcam plc
Jonathan Milner, C0-Founder of The Milner Institute, Non- Executive Director at Healx Ltd and Deputy Chairman at Abcam plc, Cambridge, United Kingdom. Having worked in the life science industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three IPOs in joining AIM. A lead investor and non-executive director of HealX Ltd, director at Horizon Discovery Group plc, GeoSpock Ltd and chairman of Axol Bioscience Ltd, Definigen Ltd, Repositive Ltd, GeneAdviser Ltd and PhoreMost Ltd.